Fareva to Acquire/Expand Pfizer Facility in VA and Add 90 New Jobs
09/01/2011
The two companies now have a manufacturing and supply agreement enabling the facility to continue production of Pfizer consumer products for global customers. All of the nearly 500 Pfizer workers employed at the site will transfer to Fareva, and 90 new jobs will be created.
Fareva will continue to operate the facility, which manufactures and packages brand-name products such as Chapstick, Advil and Robitussin. Headquartered in Luxembourg, the company employs 5,500 associates and operates 28 manufacturing facilities in Europe and emerging markets. It reported $1.2 billion in 2010 revenues.
The company CEO Bernard Fraisse said Fareva has been looking for the right opportunity to expand its manufacturing footprint into North America, and establish its pharmaceutical and cosmetics businesses in the U.S. "The Henrico County site has a talented and motivated workforce and state-of-the-art manufacturing, packaging and warehousing facilities that are a perfect fit for growing our commercial portfolio in this region."
Governor McDonnell approved a $650,000 grant from the Governor's Opportunity Fund to help Henrico County with the project, and approved an $800,000 performance-based grant from the Virginia Investment Partnership program. Moreover, the Virginia Jobs Investment Program will provide funding and services to support the company's recruitment, training and retraining activities.
Project Announcements
Jel Sert Company Expands West Chicago, Illinois, Manufacturing Operations
06/16/2025
Technomics Expands Arlington County, Virginia, Operations
06/16/2025
Conveyor Technology Expands North Little Rock, Arkansas, Manufacturing Operations
06/16/2025
Amazon Plans Salem Township-Falls Township, Pennsylvania, Operations
06/16/2025
Sentio BioSciences Expands Maryland Heights, Missouri, Production Operations
06/14/2025
Titan Mechanical Plans Defiance, Ohio, Fabrication Operations
06/12/2025
Most Read
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Navigating the new era of SCIF construction
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Get Your Mega Site ‘Project Ready’
Q2 2025